-
A Web-Based Dyadic Intervention for Colorectal Cancer
NCT05663203 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
NCT07559903 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female) · 19 locations
-
Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer
NCT06534125 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: Female · 4 locations
-
Addressing Health Literacy With a Tailored Survivorship Care Plan
NCT06674863 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: Male · 3 locations
-
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
NCT06865768 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: Male · 1 location
-
Anti-Inflammatory Challenge in Schizophrenia
NCT05823532 ·
Phase: Phase 4 ·
Ages: 18 Years to 55 Years ·
Sex: All (male and female) · 2 locations
-
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
NCT02447874 ·
Phase: Phase 1, Phase 2 ·
Ages: 7 Years to 21 Years ·
Sex: All (male and female) · 2 locations
-
Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing
NCT07562451 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 8 Years to 18 Years ·
Sex: All (male and female) · 1 location
-
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
NCT06492954 ·
Phase: Phase 1 ·
Ages: Up to 50 Years ·
Sex: All (male and female) · 1 location
-
Bioenergetic Effect of Pioglitazone in CLD-PH
NCT06336798 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
Brain Stimulation and Decision-making
NCT04099056 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 50 Years ·
Sex: All (male and female) · 1 location
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
NCT06693661 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female) · 2 locations
-
Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria
NCT06751030 ·
Phase: Not specified ·
Ages: 25 Years to 50 Years ·
Sex: Female · 3 locations
-
Cortical Electrophysiology of Response Inhibition in Parkinson's Disease
NCT06234995 ·
Phase: Phase 4 ·
Ages: 45 Years to 75 Years ·
Sex: All (male and female) · 2 locations
-
DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)
NCT05795842 ·
Phase: Not specified ·
Ages: 55 Years and older ·
Sex: All (male and female) · 1 location
-
Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
NCT06495125 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 3 locations
-
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
NCT06595160 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management
NCT07474376 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 65 Years and older ·
Sex: All (male and female) · 1 location
-
Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
NCT06731270 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 2 locations
-
Dopaminergic Therapy for Anhedonia - 2
NCT06075771 ·
Phase: Phase 4 ·
Ages: 25 Years to 55 Years ·
Sex: All (male and female) · 1 location
-
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
NCT05877859 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: Female · 1 location
-
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
NCT06423326 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
NCT05327699 ·
Phase: Early Phase 1 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 1 location
-
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
NCT06492759 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
NCT07140679 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 5 locations
-
Implementation and Cost Evaluation of Project UPLIFT
NCT06865820 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
Improving Health Literacy in African-American Prostate Cancer Patients
NCT03322891 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 25 Years to 100 Years ·
Sex: Male · 4 locations
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
NCT06495138 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 89 Years ·
Sex: All (male and female) · 1 location
-
Inflammation and Depression in People With HIV
NCT05849038 ·
Phase: Phase 2 ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 2 locations
-
Inspiring Seniors Towards Exercise Promotion to Protect Cognition
NCT06496425 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 65 Years and older ·
Sex: All (male and female) · 2 locations
-
Integrative Training Program for Pediatric Sickle Cell Pain
NCT06691867 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 12 Years to 18 Years ·
Sex: All (male and female) · 4 locations
-
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes
NCT07428746 ·
Phase: Phase 3 ·
Ages: 65 Years and older ·
Sex: Female · 1 location
-
JAK Signaling in Depression
NCT07003997 ·
Phase: Phase 2 ·
Ages: 25 Years to 55 Years ·
Sex: All (male and female) · 1 location
-
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
NCT05292339 ·
Phase: Phase 4 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 4 locations
-
Leucine in Midlife Depression
NCT06580145 ·
Phase: Phase 2 ·
Ages: 35 Years to 65 Years ·
Sex: All (male and female) · 1 location
-
Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
NCT06484244 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 50 Years to 90 Years ·
Sex: All (male and female) · 1 location
-
Low Dose Naltrexone for Pain in Patients With HIV
NCT05537935 ·
Phase: Phase 4 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 3 locations
-
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
NCT04762199 ·
Phase: Phase 1 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
Mechanisms of Behavioral Activation (BA)
NCT05548244 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 15 Years to 17 Years ·
Sex: All (male and female) · 3 locations
-
Mindfulness in Chronic Kidney Disease
NCT04099992 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 40 Years to 80 Years ·
Sex: All (male and female) · 1 location
-
Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in Kenya
NCT07764796 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity
NCT06699810 ·
Phase: Phase 4 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 2 locations
-
Moving Yourself in Space and Time: MYSTIC
NCT07697664 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 79 Years ·
Sex: All (male and female) · 1 location
-
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
NCT05928936 ·
Phase: Phase 2 ·
Ages: 40 Years to 75 Years ·
Sex: All (male and female) · 2 locations
-
Neurovascular Transduction During Exercise in Chronic Kidney Disease
NCT02947750 ·
Phase: Phase 2 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 6 locations
-
Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer
NCT05244239 ·
Phase: Phase 1 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 3 locations
-
Pectoralis Minor Release Versus Non-release in RSA
NCT06292169 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female) · 2 locations
-
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
NCT06324240 ·
Phase: Phase 1 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 4 locations
-
Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
NCT06979492 ·
Phase: Phase 4 ·
Ages: 18 Years and older ·
Sex: Female · 1 location
-
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
NCT05741164 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: Female · 2 locations
-
Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer
NCT06008730 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 1 location
-
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
NCT04725903 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: Male · 1 location
-
Sisters for Heart Health: A Community Health Worker Initiative for Improving Heart Health in Farmworker Women
NCT07111026 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 50 Years ·
Sex: Female · 1 location
-
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
NCT02604277 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 64 Years ·
Sex: All (male and female) · 1 location
-
Sympatholysis in Chronic Kidney Disease
NCT02411773 ·
Phase: Phase 1 ·
Ages: 18 Years to 75 Years ·
Sex: All (male and female) · 1 location
-
Temporal Interference in Psychiatry (TIP): Neuromodulation Using Temporal Interference
NCT07558759 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 65 Years ·
Sex: All (male and female) · 1 location
-
Testing the WeCare Intervention to Address Mental Health and Medication Adherence Challenges Among MSM in South Africa
NCT07226323 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: Male · 1 location
-
Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial
NCT07155317 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 2 locations
-
Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease
NCT07090668 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 7 Years to 18 Years ·
Sex: All (male and female) · 1 location
-
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
NCT07405476 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female) · 4 locations
-
Zesty Exercise System for Therapeutic Engagement
NCT07382674 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 40 Years and older ·
Sex: All (male and female) · 1 location
Emory University is the lead sponsor of 61 recruiting
trials.